| 0 |
ANTIMICROBIAL SUSCEPTIBILITY TEST |
1 |
0.1111 |
| 1 |
RADICAL CYSTECTOMY |
2 |
0.0571 |
| 2 |
SCLEROTHERAPY |
1 |
0.0217 |
| 3 |
BURKHOLDERIA TEST POSITIVE |
1 |
0.0081 |
| 4 |
PROCEDURAL PNEUMOTHORAX |
1 |
0.0065 |
| 5 |
ASPIRATION JOINT |
1 |
0.0050 |
| 6 |
ANORECTAL INFECTION |
1 |
0.0040 |
| 7 |
ATRIAL ENLARGEMENT |
1 |
0.0037 |
| 8 |
THERAPEUTIC EMBOLISATION |
1 |
0.0032 |
| 9 |
KLEBSIELLA TEST POSITIVE |
2 |
0.0031 |
| 10 |
SOFT TISSUE NECROSIS |
2 |
0.0029 |
| 11 |
PRODUCT NAME CONFUSION |
3 |
0.0027 |
| 12 |
DISEASE RISK FACTOR |
1 |
0.0025 |
| 13 |
GINGIVAL DISCOLOURATION |
1 |
0.0019 |
| 14 |
POST PROCEDURAL INFLAMMATION |
1 |
0.0016 |
| 15 |
INTERCEPTED PRODUCT SELECTION ERROR |
2 |
0.0015 |
| 16 |
PNEUMONIA PSEUDOMONAL |
2 |
0.0013 |
| 17 |
QRS AXIS ABNORMAL |
1 |
0.0013 |
| 18 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
0.0012 |
| 19 |
CATHETER SITE PRURITUS |
1 |
0.0011 |
| 20 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
1 |
0.0011 |
| 21 |
PRODUCT STORAGE ISSUE |
4 |
0.0011 |
| 22 |
INTUSSUSCEPTION |
1 |
0.0010 |
| 23 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
1 |
0.0010 |
| 24 |
NASAL INFLAMMATION |
1 |
0.0009 |
| 25 |
PRODUCT CONTAMINATION MICROBIAL |
1 |
0.0008 |
| 26 |
GLUCOSE URINE PRESENT |
1 |
0.0008 |
| 27 |
INCORRECT DRUG ADMINISTRATION RATE |
3 |
0.0007 |
| 28 |
MULTIPLE-DRUG RESISTANCE |
2 |
0.0006 |
| 29 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 30 |
DRUG DOSE TITRATION NOT PERFORMED |
1 |
0.0005 |
| 31 |
EXTRAVASATION |
2 |
0.0005 |
| 32 |
CATHETER SITE ERYTHEMA |
1 |
0.0005 |
| 33 |
DRUG RESISTANCE |
12 |
0.0005 |
| 34 |
LACUNAR INFARCTION |
1 |
0.0004 |
| 35 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 36 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0004 |
| 37 |
EAR CONGESTION |
1 |
0.0004 |
| 38 |
CYSTIC FIBROSIS |
2 |
0.0004 |
| 39 |
FORCED EXPIRATORY VOLUME DECREASED |
1 |
0.0004 |
| 40 |
TOOTH DISCOLOURATION |
1 |
0.0003 |
| 41 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 42 |
PATHOGEN RESISTANCE |
3 |
0.0003 |
| 43 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 44 |
ASPERGILLUS INFECTION |
2 |
0.0003 |
| 45 |
SKIN WEEPING |
1 |
0.0003 |
| 46 |
MENTAL STATUS CHANGES |
7 |
0.0003 |
| 47 |
TONGUE DISCOMFORT |
1 |
0.0002 |
| 48 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 49 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 50 |
HYSTERECTOMY |
2 |
0.0002 |
| 51 |
LUNG INFILTRATION |
2 |
0.0002 |
| 52 |
CYTOMEGALOVIRUS VIRAEMIA |
1 |
0.0002 |
| 53 |
HAEMOLYTIC ANAEMIA |
2 |
0.0002 |
| 54 |
ISCHAEMIA |
1 |
0.0002 |
| 55 |
ARTHRITIS INFECTIVE |
1 |
0.0002 |
| 56 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 57 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
1 |
0.0002 |
| 58 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 59 |
PRODUCT STORAGE ERROR |
15 |
0.0002 |
| 60 |
COVID-19 PNEUMONIA |
2 |
0.0002 |
| 61 |
MYOCLONUS |
2 |
0.0002 |
| 62 |
ENCEPHALOPATHY |
4 |
0.0002 |
| 63 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 64 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 65 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
1 |
0.0002 |
| 66 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 67 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 68 |
BRONCHIECTASIS |
1 |
0.0001 |
| 69 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 70 |
TOXIC EPIDERMAL NECROLYSIS |
2 |
0.0001 |
| 71 |
RESPIRATORY FAILURE |
9 |
0.0001 |
| 72 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 73 |
POLYURIA |
1 |
0.0001 |
| 74 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 75 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 76 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 77 |
ATELECTASIS |
1 |
0.0001 |
| 78 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 79 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 80 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 81 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 82 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 83 |
SEPTIC SHOCK |
4 |
0.0001 |
| 84 |
PRODUCT DISPENSING ERROR |
2 |
0.0001 |
| 85 |
STEVENS-JOHNSON SYNDROME |
2 |
0.0001 |
| 86 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
3 |
0.0001 |
| 87 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 88 |
BACTERAEMIA |
1 |
0.0001 |
| 89 |
NOCTURIA |
1 |
0.0001 |
| 90 |
SPINAL OPERATION |
1 |
0.0001 |
| 91 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 92 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 93 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 94 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 95 |
HAND DEFORMITY |
1 |
0.0001 |
| 96 |
SINUS CONGESTION |
1 |
0.0001 |
| 97 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 98 |
MYELODYSPLASTIC SYNDROME |
1 |
0.0001 |
| 99 |
RENAL INJURY |
2 |
0.0001 |
| 100 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 101 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 102 |
CANDIDA INFECTION |
1 |
0.0001 |
| 103 |
THERAPY CESSATION |
3 |
0.0001 |
| 104 |
DELIRIUM |
2 |
0.0001 |
| 105 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 106 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 107 |
FRACTURE |
1 |
0.0001 |
| 108 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 109 |
ACUTE KIDNEY INJURY |
8 |
0.0001 |
| 110 |
CHOLESTASIS |
1 |
0.0001 |
| 111 |
GLAUCOMA |
1 |
0.0001 |
| 112 |
ERUCTATION |
1 |
0.0001 |
| 113 |
PREGNANCY |
1 |
0.0000 |
| 114 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 115 |
MOUTH ULCERATION |
1 |
0.0000 |
| 116 |
RECTAL HAEMORRHAGE |
2 |
0.0000 |
| 117 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 118 |
MELAENA |
1 |
0.0000 |
| 119 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 120 |
CHROMATURIA |
1 |
0.0000 |
| 121 |
HEPATIC ENZYME INCREASED |
3 |
0.0000 |
| 122 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 123 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 124 |
HEPATIC CANCER |
1 |
0.0000 |
| 125 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 126 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 127 |
HEPATITIS |
1 |
0.0000 |
| 128 |
OFF LABEL USE |
34 |
0.0000 |
| 129 |
RASH GENERALISED |
1 |
0.0000 |
| 130 |
JAUNDICE |
1 |
0.0000 |
| 131 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 132 |
RASH PRURITIC |
2 |
0.0000 |
| 133 |
PALLOR |
1 |
0.0000 |
| 134 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 135 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 136 |
HAEMOPTYSIS |
1 |
0.0000 |
| 137 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 138 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 139 |
HYPOTENSION |
7 |
0.0000 |
| 140 |
SEIZURE |
4 |
0.0000 |
| 141 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 142 |
APHASIA |
1 |
0.0000 |
| 143 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 144 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 145 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 146 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 147 |
FUNGAL INFECTION |
1 |
0.0000 |
| 148 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 149 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 150 |
HYPERKALAEMIA |
1 |
0.0000 |
| 151 |
HYPOXIA |
1 |
0.0000 |
| 152 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 153 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 154 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 155 |
DYSURIA |
1 |
0.0000 |
| 156 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 157 |
DYSKINESIA |
1 |
0.0000 |
| 158 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 159 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 160 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 161 |
HYPOACUSIS |
1 |
0.0000 |
| 162 |
MENTAL DISORDER |
1 |
0.0000 |
| 163 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 164 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 165 |
TINNITUS |
1 |
0.0000 |
| 166 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 167 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 168 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 169 |
PYREXIA |
7 |
0.0000 |
| 170 |
DRY EYE |
1 |
0.0000 |
| 171 |
CELLULITIS |
1 |
0.0000 |
| 172 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 173 |
OEDEMA |
1 |
0.0000 |
| 174 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 175 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 176 |
SEPSIS |
2 |
0.0000 |
| 177 |
PANCYTOPENIA |
1 |
0.0000 |
| 178 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 179 |
HYPONATRAEMIA |
1 |
0.0000 |
| 180 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 181 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 182 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 183 |
CATARACT |
1 |
0.0000 |
| 184 |
JOINT SWELLING |
2 |
0.0000 |
| 185 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 186 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 187 |
PNEUMONIA |
5 |
0.0000 |
| 188 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 189 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 190 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 191 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 192 |
AGITATION |
1 |
0.0000 |
| 193 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 194 |
THROMBOSIS |
1 |
0.0000 |
| 195 |
DRY MOUTH |
1 |
0.0000 |
| 196 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 197 |
CARDIAC ARREST |
1 |
0.0000 |
| 198 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 199 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 200 |
COVID-19 |
2 |
0.0000 |
| 201 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 202 |
SWELLING |
1 |
0.0000 |
| 203 |
DYSPNOEA |
6 |
0.0000 |
| 204 |
DYSPHAGIA |
1 |
0.0000 |
| 205 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 206 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 207 |
HEART RATE INCREASED |
1 |
0.0000 |
| 208 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 209 |
SINUSITIS |
1 |
0.0000 |
| 210 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 211 |
ILLNESS |
1 |
0.0000 |
| 212 |
HEADACHE |
6 |
0.0000 |
| 213 |
HAEMORRHAGE |
1 |
0.0000 |
| 214 |
OVERDOSE |
2 |
0.0000 |
| 215 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 216 |
CONSTIPATION |
2 |
0.0000 |
| 217 |
WEIGHT INCREASED |
2 |
0.0000 |
| 218 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 219 |
CHILLS |
1 |
0.0000 |
| 220 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 221 |
NAUSEA |
6 |
0.0000 |
| 222 |
RENAL FAILURE |
1 |
0.0000 |
| 223 |
DRY SKIN |
1 |
0.0000 |
| 224 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 225 |
NEUTROPENIA |
1 |
0.0000 |
| 226 |
COUGH |
2 |
0.0000 |
| 227 |
DEATH |
6 |
0.0000 |
| 228 |
INFECTION |
1 |
0.0000 |
| 229 |
MALAISE |
3 |
0.0000 |
| 230 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 231 |
PAIN |
4 |
0.0000 |
| 232 |
HOSPITALISATION |
1 |
0.0000 |
| 233 |
VOMITING |
3 |
0.0000 |
| 234 |
DIZZINESS |
3 |
0.0000 |
| 235 |
CHEST PAIN |
1 |
0.0000 |
| 236 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 237 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 238 |
PRURITUS |
2 |
0.0000 |
| 239 |
FATIGUE |
4 |
0.0000 |
| 240 |
SOMNOLENCE |
1 |
0.0000 |
| 241 |
ERYTHEMA |
1 |
0.0000 |
| 242 |
HYPERTENSION |
1 |
0.0000 |
| 243 |
DIARRHOEA |
3 |
0.0000 |
| 244 |
DECREASED APPETITE |
1 |
0.0000 |
| 245 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 246 |
DRUG INEFFECTIVE |
5 |
0.0000 |
| 247 |
INSOMNIA |
1 |
0.0000 |
| 248 |
WEIGHT DECREASED |
1 |
0.0000 |
| 249 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 250 |
FALL |
1 |
0.0000 |
| 251 |
ARTHRALGIA |
1 |
0.0000 |
| 252 |
RASH |
1 |
0.0000 |